Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
04 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-announces-first-patient-dosed-in-phase-2-clinical-trial-of-oral-immuno-oncology-drug-tu2218-302267526.html
24 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-presents-promising-clinical-data-from-phase-1-of-its-hemophilia-treatment-candidate-tu7710-at-isth-2024-302180104.html
01 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-presents-phase-1b-interim-results-for-tu2218-in-combination-with-pembrolizumab-at-asco-2024-annual-meeting-302160236.html
08 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-announces-positive-topline-data-from-phase-2a-trial-of-merigolix-in-patients-with-moderate-to-severe-endometriosis-associated-pain-302139490.html
26 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-submits-cta-for-phase-1b-clinical-trial-of-tu7710-a-long-acting-recombinant-activated-factor-vii-in-hemophilia-a-or-b-patients-302099347.html
29 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tiumbio-secures-krw-38-5-billion-in-anticipation-of-upcoming-clinical-data-302023671.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?